» Articles » PMID: 34448503

Effects of Desmopressin Acetate Administration in Healthy Dogs Receiving Prednisolone

Overview
Date 2021 Aug 27
PMID 34448503
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glucocorticoids are used for a variety of purposes in veterinary medicine but often are associated with clinically important adverse effects. Polyuria and polydipsia are the most frustrating adverse effects noted by owners.

Objective: To determine whether administration of desmopressin ameliorates polyuria and polydipsia associated with prednisolone administration.

Animals: Seven healthy adult Walker Hounds.

Methods: Prospective hypothesis testing study. Daily water intake and urine specific gravity (USG) were measured in dogs under 4 separate sequential conditions: no medications (C), prednisolone only (P), prednisolone and desmopressin (PD), and prednisolone after discontinuation of desmopressin (PAD).

Results: When compared to baseline, 6 of 7 dogs became polydipsic after administration of prednisolone (0.5 mg/kg PO q12h). When desmopressin (5 μg/dog SC q12h) was administered to dogs receiving prednisolone, significant decreases in water intake and serum sodium concentration occurred, and USG increased significantly.

Conclusions And Clinical Importance: Administration of desmopressin to dogs receiving prednisolone significantly decreased water intake and serum sodium concentration, and increased USG. Our results suggest that, in some dogs, desmopressin ameliorates the most important adverse effect of prednisolone noted by owners, but that hyponatremia is an important complication associated with desmopressin use.

Citing Articles

Orally administered prednisolone decreases plasma arginine vasopressin and serum copeptin concentrations in healthy dogs.

Paulin M, Mehrabanpour D, Unniappan S, Snead E J Vet Intern Med. 2025; 39(1):e17304.

PMID: 39831546 PMC: 11744477. DOI: 10.1111/jvim.17304.


Perspectives on pharmacologic strategies in the management of meningoencephalomyelitis of unknown origin in dogs.

Beasley M, Shores A Front Vet Sci. 2023; 10:1167002.

PMID: 37234070 PMC: 10205981. DOI: 10.3389/fvets.2023.1167002.


Effects of desmopressin acetate administration in healthy dogs receiving prednisolone.

Galati P, Archer T, Jolly R, Sullivant A, Wills R, Lathan P J Vet Intern Med. 2021; 35(5):2271-2276.

PMID: 34448503 PMC: 8478070. DOI: 10.1111/jvim.16250.

References
1.
Neveus T, Fonseca E, Franco I, Kawauchi A, Kovacevic L, Nieuwhof-Leppink A . Management and treatment of nocturnal enuresis-an updated standardization document from the International Children's Continence Society. J Pediatr Urol. 2020; 16(1):10-19. DOI: 10.1016/j.jpurol.2019.12.020. View

2.
Whitley N, Day M . Immunomodulatory drugs and their application to the management of canine immune-mediated disease. J Small Anim Pract. 2011; 52(2):70-85. DOI: 10.1111/j.1748-5827.2011.01024.x. View

3.
Bahr V, Franzen N, Oelkers W, Pfeiffer A, Diederich S . Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man. Eur J Endocrinol. 2006; 155(6):845-8. DOI: 10.1530/eje.1.02299. View

4.
Galati P, Archer T, Jolly R, Sullivant A, Wills R, Lathan P . Effects of desmopressin acetate administration in healthy dogs receiving prednisolone. J Vet Intern Med. 2021; 35(5):2271-2276. PMC: 8478070. DOI: 10.1111/jvim.16250. View

5.
Goggs R . Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia. Vet Clin North Am Small Anim Pract. 2020; 50(6):1327-1349. DOI: 10.1016/j.cvsm.2020.07.010. View